Sami-Sabinsa to Highlight Research on Shagandha™ Ashwagandha for Stress Management Benefits at Expo West 2024
February 13, 2024
Sami-Sabinsa Gains First Approval for ANVISA’s IN28 in Brazil for C3 Reduct®
January 17, 2024
Founded by Dr. Muhammed Majeed, an internationally acclaimed scientist, entrepreneur and pioneer in the field of evidence-based natural ingredients, Sami-Sabinsa Group is a research-oriented multinational health science company.